Ligustrazine phosphate injection (for intravenous injection)
Function and Efficacy
Ligustrazine phosphate has the effects of anti-platelet aggregation and disaggregation, dilating arterioles, improving microcirculation, improving cerebral blood flow, and promoting blood circulation and removing blood stasis. Toxicological studies have shown that the LD50 of ligustrazine injected into the tail vein of mice is 239 mg/kg.
Ingredients
Ligustrazine phosphate
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LigustrazinePhosphateIngredients |
Anti-platelet aggregation and disaggregation, dilation of arterioles, improvement of microcirculation, improvement of cerebral blood flow and blood circulation and stasis-removing effects More |
848645-86-3 | 6 |
Appearance
This product is a colorless clear liquid.
Indication
Used for ischemic cerebrovascular diseases (such as cerebral ischemia, cerebral thrombosis, cerebral embolism).
Usage and Dosage
Intravenous drip: 50-100 mg at a time, diluted in 250-500 ml of 5%-10% glucose injection, slowly drip, preferably within 3-4 hours, once a day, 10-15 days as a course of treatment or follow the doctor's advice.
Adverse Reactions
Occasionally, stomach discomfort, dry mouth, and drowsiness may occur, which can be relieved by stopping the medication.
Precautions
Occasionally, stomach discomfort, dry mouth, and drowsiness may occur, which can be relieved by stopping the medication.
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
5ml:100mg
Manufacturer
Jilin Sihuan Pharmaceutical Company Limited
-
Founded in:
2007-12-27 -
Address:
No. 66, Xiangjiang Road, Meihekou City, Jilin Province -
Tax NO.:
91220581668769338X -
Registered Funds:
62.5 million yuan -
Email: